Cannabidiol Exerts a Neuroprotective and Glia-Balancing Effect in the Subacute Phase of Stroke

Pharmacological agents limiting secondary tissue loss and improving functional outcomes after stroke are still limited. Cannabidiol (CBD), the major non-psychoactive component of <i>Cannabis sativa</i>, has been proposed as a neuroprotective agent against experimental cerebral ischemia....

Full description

Bibliographic Details
Main Authors: Erika Meyer, Phillip Rieder, Davide Gobbo, Gabriella Candido, Anja Scheller, Rúbia Maria Weffort de Oliveira, Frank Kirchhoff
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/21/12886